STOCK TITAN

Pediatrix Medical Group, Inc. SEC Filings

MD NYSE

Pediatrix Medical Group, Inc. filings document the public-company disclosures of a Florida physician-services operator focused on obstetrics, maternal-fetal medicine, neonatology and pediatric subspecialty care. Recent Form 8-K reports furnish operating results, including net revenue, earnings measures, same-unit revenue drivers, reimbursement factors, patient volume trends and hospital-based practice activity.

Proxy and governance filings cover director elections, shareholder voting results, executive compensation, pay-versus-performance data and the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan. Other material-event reports address board appointments, Regulation FD disclosures and common-stock repurchase authorizations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.04%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.84%
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.84%
Tags
current report

FAQ

How many Pediatrix Medical Group (MD) SEC filings are available on StockTitan?

StockTitan tracks 37 SEC filings for Pediatrix Medical Group (MD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Pediatrix Medical Group (MD)?

The most recent SEC filing for Pediatrix Medical Group (MD) was filed on August 5, 2025.